Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Harvard Business School
McKinsey
Medtronic
Dow

Last Updated: August 19, 2022

XYOSTED (AUTOINJECTOR) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Xyosted (autoinjector) patents expire, and what generic alternatives are available?

Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. There are eighteen patents protecting this drug.

This drug has sixty-nine patent family members in thirteen countries.

The generic ingredient in XYOSTED (AUTOINJECTOR) is testosterone enanthate. There are sixty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the testosterone enanthate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Xyosted (autoinjector)

A generic version of XYOSTED (AUTOINJECTOR) was approved as testosterone enanthate by WATSON PHARMS INC on December 31st, 1969.

  Try it Free

Drug patent expirations by year for XYOSTED (AUTOINJECTOR)
Pharmacology for XYOSTED (AUTOINJECTOR)
Drug Class Androgen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for XYOSTED (AUTOINJECTOR)

XYOSTED (AUTOINJECTOR) is protected by eighteen US patents.

Patents protecting XYOSTED (AUTOINJECTOR)

Needle assisted jet injection administration of testosterone compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Injection device with cammed RAM assembly
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted jet injection device having reduced trigger force
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Testosterone ester triglyceride formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted jet injection administration of testosterone compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Needle assisted injection device having reduced trigger force
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Injection device with cammed ram assembly
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted injection administration of testosterone compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Hematocrit modulation through needle assisted jet injection of testosterone
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Syringe shock absorber for use in an injection device
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe jet injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe jet injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe jet injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe jet injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Prefilled syringe jet injector
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted jet injection device having reduced trigger force
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Needle assisted jet injection administration of testosterone compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING TESTOSTERONE ENANTHATE SUBCUTANEOUSLY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for XYOSTED (AUTOINJECTOR)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 See Plans and Pricing See Plans and Pricing
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-001 Sep 28, 2018 See Plans and Pricing See Plans and Pricing
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for XYOSTED (AUTOINJECTOR)

See the table below for patents covering XYOSTED (AUTOINJECTOR) around the world.

Country Patent Number Title Estimated Expiration
Canada 2957679 AMORTISSEUR DE CHOCS POUR SERINGUE, DESTINE A ETRE UTILISE DANS UN DISPOSITIF D'INJECTION (A SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE) See Plans and Pricing
China 1212867 See Plans and Pricing
World Intellectual Property Organization (WIPO) 0009186 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Moodys
Mallinckrodt
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.